Cancer news

The latest news in cancer research, health and policy by Cancer Research UK.

We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy. 

Ovarian Cancer

An existing blood test for ovarian cancer has been re-evaluated. The results are in

Researchers have found an existing ovarian cancer blood test is far more predictive than originally thought and could potentially pick up other forms of cancer.

Are differences in treatment driving variation in ovarian cancer survival internationally?

The latest ovarian cancer data from the ICBP reveals that while more people are surviving their cancer, there’s still a long way to go.

Three new treatment options approved for NHS use in Scotland

The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland

The making of a living ovarian cancer biobank

Our scientists are growing a living ovarian cancer biobank in Manchester.

Research suggests statins could lower ovarian cancer risk

A genetic study has found evidence to suggest that women who take statins in the long term could be less likely to develop ovarian cancer.

Targeted ovarian cancer drug made available to more people on NHS in England

NICE has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England.

Targeted ovarian cancer drug made more widely available on the NHS in Scotland

A targeted cancer drug has been approved for use on the NHS in Scotland for patients with newly diagnosed ovarian cancer that’s responded to chemotherapy.

Advanced ovarian cancer treatment approved for Cancer Drugs Fund

A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund.

Advanced ovarian cancer drug gets initial ‘no’ for NHS in England

A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.

Ovarian cancer drug will be offered earlier to NHS patients in England

A targeted drug for advanced ovarian cancer will be more widely available for certain patients on the NHS in England.

Pages